Empagliflozin ameliorates symptoms of diabetes and renal tubular dysfunction in a rat model of diabetes with enlarged kidney (DEK).
Autor: | Domon, Ayaka1 (AUTHOR), Katayama, Kentaro1 (AUTHOR), Sato, Touko2 (AUTHOR), Tochigi, Yuki1 (AUTHOR), Tazaki, Hiroyuki2 (AUTHOR), Suzuki, Hiroetsu1 (AUTHOR) hiroetsu@nvlu.ac.jp |
---|---|
Zdroj: | PLoS ONE. 5/4/2021, Vol. 16 Issue 5, p1-16. 16p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |